Todd Brandt, MD
Urology · Woodbury, MNNPI 1417944604
Payments from drug & device makers
Across 15 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$56
- SRS Medical Systems, Inc.$40
- AbbVie$30
- Coloplast$27
- Johnson & Johnson$19
- Pfizer$19
- plus $89 from 6 others
What the payments were for
- Food & beverage$282100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $56 |
| SRS Medical Systems, Inc. | 1 | $40 |
| AbbVie | 2 | $30 |
| Coloplast | 2 | $27 |
| Johnson & Johnson | 1 | $19 |
| Pfizer | 1 | $19 |
| Myovant Sciences Inc. | 1 | $17 |
| Progenics Pharmaceuticals, Inc. | 1 | $16 |
| Calyxo, Inc. | 1 | $15 |
| Urogen Pharma, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Antares Pharma, Inc. | 1 | $13 |
How this compares
$282 in reported general payments places this provider in the 25th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 84 | $1,064,750 |
| Everolimus | 14 | $190,822 |
| Abiraterone Acetate | 51 | $88,317 |
| OrgovyxRelugolix | 28 | $69,846 |
| MyrbetriqMirabegron | 15 | $14,522 |
| Tamsulosin Hcl | 786 | $12,952 |
| Finasteride | 296 | $4,979 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 134 | $2,838 |
| Solifenacin Succinate | 47 | $1,668 |
| Oxybutynin Chloride ErOxybutynin Chloride | 76 | $1,667 |
| Trimethoprim | 22 | $1,598 |
| Methenamine Hippurate | 12 | $1,469 |
| Cephalexin | 216 | $1,378 |
| Bicalutamide | 17 | $1,108 |
| Oxybutynin Chloride | 63 | $1,055 |
Paid to pharmacies, not to this prescriber.
Other urology in Woodbury
- Aaron MilbankWoodbury$261K
- Steven SiegelWoodbury$211K
- Jodi MichaelsWoodbury$199K
- Spencer HartWoodbury$82K
- David PrallWoodbury$14K
- Mikhail RegelmanWoodbury$10K
- Anthony PolcariWoodbury$7K
- Samuel KieleyWoodbury$6K
- Paras ShahRochester$1.4M
- Joseph ZabellEdina$565K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.